PRINCETON, N.J.—Feb. 17, 2021– Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today announced that it will release preliminary financial results for the fourth quarter and full year of 2020 after the market close on 星期四, 三月 4, 2021. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.
Investors interested in listening to the conference call may do so by dialing (833) 360-0946 for domestic callers or (914) 987-7661 for international callers, followed by Conference ID: 6546156. A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
关于Certara
Certara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Certara的客户覆盖全球1,650多家生物制药公司61个国家和地区的、领先学术机构和主要监管机构。
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
媒体联系人：
Elizabeth Tang, Ph.D.
Finn Partners
elizabeth.tang@finnpartners.com
